Skip to main content

New Products

  • FDA approves new drug for short bowel syndrome

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug to treat a condition that affects people who have had their intestines partially or completely removed, the agency said Friday.

    The FDA announced the approval of NPS Pharmaceuticals' Gattex (teduglutide) for daily injection in adults with short bowel syndrome who need additional nutrition from intravenous feeding. SBS results from partial or complete surgical removal of the small or large intestine, which can lead to poor absorption of fluids and nutrients from food.

  • FDA approves biotech drug for reducing symptoms of severe chickenpox infection

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said Friday.

    The FDA announced the approval of Cangene Corp.'s Varizig (varicella zoster immune globulin [human]) for varicella zoster, the virus that causes chickenpox. The FDA said Varizig was the only FDA-approved immune globulin for the virus after exposure.

  • Burt's Bees offering winter skin protection

    NEW YORK — Burt’s Bees is looking to help consumers protect their skin against cold weather conditions this winter with several new moisturizing products. 
  

    
Burt’s Bees New Intense Hydration day lotion: Infused with clary sage, Burt’s Bees Intense Hydration day lotion deeply hydrates dry skin. This noncomedogenic day lotion also aims to reduce line and wrinkles, for a youthful, healthy glow.  



  • PediaCare Cold & Flu Hydration introduced

    TARRYTOWN, N.Y. — A new product from the PediaCare line is designed to keep children hydrated when they have a cold or flu.

    Prestige Brands Holdings announced the launch of PediaCare Cold & Flu Hydration, designed to ensure children get needed fluids and electrolytes. The product replenishes nutrients lost from illness and provides immune-boosting antioxidants, with less sugar than sports drinks, soda and juices.

  • Mylan, Orion settle Parkinson's disease drug case

    PITTSBURGH — Generic drug maker Mylan has settled with Orion over a drug used to treat Parkinson's disease, Mylan said Thursday.

    The company said it reached a settlement with Orion to resolve patent litigation concerning a generic version of Orion's drug Comtan (entacapone) tablets in the 200-mg strength. The drug is used with levodopa-carbidopa therapy to treat Parkinson's patients who experience signs and symptoms of end-of-dose "wearing off."

  • New La Roche-Posay moisturizer mattifies skin, refines pores

    NEW YORK — Looking to battle skinny skin and enlarged pores, La Roche-Posay has developed the new Effaclar Mat Daily Mattifying + Pore-Refining Moisturizer.

    For the first time, this formula contains a unique combination of ingredients that neutralizes shine for lastingly matte, clear and balanced skin with tightened pores, the manufacturer stated.
     

  • OPI creates limited-edition collection inspired by 'Oz The Great and Powerful'

    NEW YORK — OPI has announced the launch of six limited-edition nail lacquers and a new Liquid Sand shade, inspired by Disney’s "Oz The Great and Powerful" film that opens in theaters on March 8, 2013.

    With a mix of soft cream and warm glitter shades, the line is ideal for layering to create rich, complex looks. In addition to the Liquid Sand nail lacquer in "What Wizardry is This?," the promotion includes:
     

  • ScarAway sheets to reduce C-section scars available at Buybuy Baby stores

    GUILFORD, Conn. — A sheet designed to fade and flatten C-section scars is available at Buybuy Baby stores, the manufacturer said.

    ScarAway Silicone C-Section scar sheets used to be available only through hospitals but are now available at Buybuy Baby stores nationwide and online, manufacturer Mitchell-Vance Labs said.

X
This ad will auto-close in 10 seconds